Lin Hu

3.1k total citations · 2 hit papers
105 papers, 2.2k citations indexed

About

Lin Hu is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Lin Hu has authored 105 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 14 papers in Oncology and 14 papers in Biomedical Engineering. Recurrent topics in Lin Hu's work include Nanoplatforms for cancer theranostics (9 papers), Antibiotic Use and Resistance (9 papers) and Cancer Research and Treatments (7 papers). Lin Hu is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Antibiotic Use and Resistance (9 papers) and Cancer Research and Treatments (7 papers). Lin Hu collaborates with scholars based in China, United States and Canada. Lin Hu's co-authors include Kai Yang, Kai Wang, Pei Pei, Yuhong Wang, Teng Liu, Fuliang Hu, Wenhao Shen, Lingchuan Guo, Xiangli Meng and Wenhao Shen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Lin Hu

99 papers receiving 2.2k citations

Hit Papers

CST1 inhibits ferroptosis and promotes gastric cancer met... 2022 2026 2023 2024 2022 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Hu China 29 900 417 291 291 273 105 2.2k
Yifei Chen China 28 1.3k 1.4× 416 1.0× 143 0.5× 287 1.0× 158 0.6× 145 2.9k
Hsing‐Chun Kuo Taiwan 30 1.1k 1.2× 313 0.8× 207 0.7× 241 0.8× 87 0.3× 84 2.5k
Yao Li China 27 1.1k 1.2× 323 0.8× 413 1.4× 247 0.8× 86 0.3× 113 2.3k
Wenjuan Liu China 25 754 0.8× 277 0.7× 215 0.7× 125 0.4× 151 0.6× 161 2.0k
Hu Liu China 25 1.1k 1.3× 412 1.0× 306 1.1× 178 0.6× 766 2.8× 121 2.6k
Hui Luo China 29 1.2k 1.4× 608 1.5× 352 1.2× 263 0.9× 150 0.5× 126 2.8k
Yichen Liu China 22 1.3k 1.5× 840 2.0× 729 2.5× 291 1.0× 246 0.9× 111 2.5k
Xiaorong Zhou China 27 976 1.1× 272 0.7× 163 0.6× 597 2.1× 74 0.3× 120 2.2k
Mohamed F. Elshal Egypt 22 832 0.9× 277 0.7× 158 0.5× 284 1.0× 142 0.5× 70 2.4k
Kati Erdmann Germany 22 1.3k 1.5× 361 0.9× 274 0.9× 84 0.3× 102 0.4× 59 2.0k

Countries citing papers authored by Lin Hu

Since Specialization
Citations

This map shows the geographic impact of Lin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Hu more than expected).

Fields of papers citing papers by Lin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Hu. The network helps show where Lin Hu may publish in the future.

Co-authorship network of co-authors of Lin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Hu. A scholar is included among the top collaborators of Lin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Hu. Lin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuhong, Lin Hu, Lei Wang, et al.. (2025). Engineered Escherichia coli Nissle 1917 targeted delivery of extracellular PD-L1-mFc fragment for treating inflammatory bowel disease. Acta Pharmaceutica Sinica B. 15(11). 6019–6033. 3 indexed citations
2.
He, Qing‐Yu, Yan Gao, Guangming Zhou, et al.. (2025). Novel bio-carriers for radionuclide delivery in cancer radiotherapy. Coordination Chemistry Reviews. 533. 216557–216557. 5 indexed citations
3.
Chen, Bin, et al.. (2025). A hierarchical cooperative eco-driving and energy management strategy of hybrid electric vehicle based on improved TD3 with multi-experience. Energy Conversion and Management. 326. 119508–119508. 10 indexed citations
4.
Chen, Bin, et al.. (2025). Energy management of electric vehicles based on improved long short term memory network and data-enabled predictive control. Applied Energy. 384. 125456–125456. 2 indexed citations
5.
Shen, Wenhao, Shu Liu, Pei Pei, et al.. (2025). A novel radio-immunotherapy strategy: Gut microbiota metabolite combined with radioactive hydrogel for the treatment of low rectal cancer. Biomaterials. 322. 123386–123386. 1 indexed citations
6.
Song, Yujun, Yifan Wang, Yihua Xu, et al.. (2025). Chimeric Antigen Receptor Cells Solid Tumor Immunotherapy Assisted by Biomaterials Tools. ACS Applied Materials & Interfaces. 17(7). 10246–10264. 1 indexed citations
7.
Wushouer, Haishaerjiang, Lin Hu, Xiaodong Guan, et al.. (2025). Integrated assessment of antimicrobial stewardship in carbapenem resistant Klebsiella pneumoniae prevalent hospitals in China: a multidisciplinary surveillance network-based survey. Antimicrobial Resistance and Infection Control. 14(1). 32–32. 1 indexed citations
8.
Hu, Lin, Erik Loewen Friesen, Nadia Minian, et al.. (2025). Conversational agent interventions in diabetes care: a systematic review. Diabetes Research and Clinical Practice. 228. 112429–112429.
9.
Liu, Teng, et al.. (2024). Engineered delivery platform based on bacterial outer membrane vesicles for efficient labeling of 131I and improved radio-immunotherapy. Chemical Engineering Journal. 490. 151837–151837. 7 indexed citations
10.
Su, Zhiyue, Wenshu Li, Zhe Lei, et al.. (2024). Regulation of Angiogenesis by Non-Coding RNAs in Cancer. Biomolecules. 14(1). 60–60. 8 indexed citations
11.
Wang, Xuanyu, Guangyu Xu, Wei Xu, et al.. (2024). Harnessing Bacterial Membrane Components for Tumor Vaccines: Strategies and Perspectives. Advanced Healthcare Materials. 13(26). e2401615–e2401615. 10 indexed citations
12.
Pei, Pei, Yuhong Wang, Wenhao Shen, et al.. (2024). Oxygen‐driven cuproptosis synergizes with radiotherapy to potentiate tumor immunotherapy. SHILAP Revista de lepidopterología. 5(3). 44 indexed citations
13.
Hu, Lin, et al.. (2024). A graph pattern mining framework for large graphs on GPU. The VLDB Journal. 34(1). 1 indexed citations
14.
Zhang, Yanxiang, Pei Pei, Hailin Zhou, et al.. (2023). Nattokinase-Mediated Regulation of Tumor Physical Microenvironment to Enhance Chemotherapy, Radiotherapy, and CAR-T Therapy of Solid Tumor. ACS Nano. 17(8). 7475–7486. 37 indexed citations
16.
Wushouer, Haishaerjiang, Tao Huang, Yue Zhou, et al.. (2023). The changes of different restriction level adjustments on antibiotic use in China. International Journal of Antimicrobial Agents. 63(2). 107073–107073. 4 indexed citations
17.
Wushouer, Haishaerjiang, Yue Zhou, Lin Hu, et al.. (2023). Inpatient antibacterial use trends and patterns, China, 2013–2021. Bulletin of the World Health Organization. 101(4). 248–261B. 9 indexed citations
18.
Hu, Lin, et al.. (2022). The Impact of Sanming Healthcare Reform on Antibiotic Appropriate Use in County Hospitals in China. Frontiers in Public Health. 10. 936719–936719. 9 indexed citations
20.
Hu, Lin. (2006). A rapid detection of mtDNA G11778A mutation by a SNP-Strip. Chinese Journal of Optometry & Ophthalmology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026